Thomson Medical Group Ltd. · SGX:A50
Thomson Medical — H1 2024 Earnings Presentation
22 slides from Thomson Medical's earnings presentation, Feb 19, 2024
Slide 1: Thomson Medical Group Limited 1H2024 Results Briefing
CONFIDENTIAL 19 February 2024 THOMSON MEDICAL GROUP LIMITED 1H2024 Results Briefing 0
Slide 2: Disclaimer
Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herein, the oral p
Slide 3: 1 Group Overview 2 1H FY2024 Financial Highlights 3 Key Operational Statistics
Strictly Private & Confidential 1 Group Overview 2 1H FY2024 Financial Highlights 3 Key Operational Statistics 4 Future Growth Plans
Slide 4: Group Overview
1 Group Overview Confidential I 3
Slide 5: Key Businesses
Key Businesses 100% ▪ One of the largest private providers of healthcare services for women and children in Singapore ▪ 34 clinics and centres today compared to 16 in 2010 S$114m 1H24 Revenue ▪ Multi-disciplinary healthcare company listed on ~70% Bursa Malaysia ▪ Operates Thomson Hospital Kota Daman
Slide 6: Thomson Medical Pte Ltd (TMPL)
Thomson Medical Pte Ltd (“TMPL”) Hospital Operations & Ancillary Services Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services, as well as diagnostic imaging,
Slide 7: TMC Life Sciences Berhad (TMCLS)
TMC Life Sciences Berhad (“TMCLS”) Hospital Operations & Ancillary Services In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medical technology and infrastructure to deliver quality and affordable
Slide 8: Healthcare Assets in Singapore and Malaysia
Healthcare Assets in Singapore and Malaysia Singapore Malaysia 187 34 350 5 licensed beds(1) clinics & centres licensed beds(1)(2) fertility centres Sembawang Choa Chu Kang Novena Punggol Medical Centre Penang Sengkang Bukit Batok/ Bukit Panjang Serangoon Future growth Tampines Ipoh United Square Ju
Slide 9: FV Hospital: A world-class healthcare delivery platform in Vietnam
FV Hospital: A world-class healthcare delivery platform in Vietnam Snapshot of the FV Group’s Network FV Group overview FV Hanoi City • Years in operation: 20+ Hospital 1 ACC Clinic • Location: District 7, Ho Chi Minh City (“Hanoi Clinic”) • Modern multi-specialty private tertiary care hospital offe
Slide 10: FV Hospital: Premier Platform with Comprehensive Tertiary Offerings
FV Hospital: Premier Platform with Comprehensive Tertiary Offerings complemented by Strong Expansion Plan and Reputed Doctors First JCI Accredited general hospital in South Vietnam. 3 consecutive JCI Accreditations, Underpinning the Premium Quality of Care Provided Across FV’s Platform Key CoEs Onco
Slide 11: 1H FY2024 Financial Highlights
2 1H FY2024 Financial Highlights Confidential I 10
Slide 12: Group Financial Highlights – 1H FY2024
Group Financial Highlights – 1H FY2024 Profit or Loss Balance Sheet 8.6% Revenue $168.1m Successfully raised S$150.0m bonds in May/Jul 2023 (1) 20.3% Adjusted EBITDA $44.2m Total assets of $1.89b as of 31 Dec 2023 79.7% PAT $4.9m (1) Adjusted for one-off transactions and non-recurring costs. Confide
Slide 13: Historical Financial Highlights
Historical Financial Highlights (1) REVENUE ($’mil) ADJUSTED EBITDA ($’mil) PROFIT AFTER TAX ($’mil) YoY ↓ 79.7% YoY ↓20.3% 24.6 55.5 3.4 YoY ↓8.6% 9.9 13.9 4.9 YoY 44.2 3.5 ↑150.0% 184.0 39.5 YoY 8.5 0.2 ↑62.6% 168.1 33.3 6.4 16.1 145.4 0.2 YoY 44.8 YoY 23.0 ↓48.3% 0.2 ↑20.7% 17.2 54.2 36.3 46.8 Yo
Slide 14: Financial Highlights (Proforma)
Financial Highlights (Proforma) (1) REVENUE ($’mil) ADJUSTED EBITDA ($’mil) (2) YoY YoY ↑ 21.2% ↓ 0.4% YoY YoY ↓8.6% ↓20.3% 55.5 55.3 223.2 0.2 9.9 11.1 YoY 44.2 184.0 55.1 ↑62.6% 0.2 168.1 0.2 16.1 16.1 44.8 YoY ↑20.7% 54.2 54.2 46.8 YoY ↓38.5% 28.8 28.8 139.0 YoY ↓18.2% 113.7 113.7 (1.2) (0.7) (0.
Slide 15: Geographical Segments – 1H FY2024 (Proforma)
Geographical Segments – 1H FY2024 (Proforma) (1) (2) Revenue Adjusted EBITDA (S$ in millions) (S$ in millions) $0.2m -$0.7m $0.2m $55.1m -$1.2m $11.1m -1% $9.9m -2% 20% $44.8m 25% 24% 18% 1H FY2023 1H FY2024 1H FY2023 1H FY2024 $184.0m $223.2m 51% $55.5m $55.3m 52% $28.8m $113.7m 76% 24% 84% $16.1m
Slide 16: Key Leverage Ratios
KEY LEVERAGE RATIOS Jun 2023 Dec 2023 Dec 2023 S$’m (Actual) (Actual) (Proforma)(1) Total Debts 747.8 1,106.9 1,106.9 Cash (286.6) (271.9) (271.9) Net Debts 461.2 835.0 835.0 Equity 575.4 563.3 563.3 EBITDA 103.3 38.4 49.5 Adjusted EBITDA(2) 106.6 44.2 55.3 Net Debts / Equity 0.8x 1.5x 1.5x Net Debt
Slide 17: Key Operational Statistics
3 Key Operational Statistics Confidential I 16
Slide 18: Key Operating Statistics
Key Operating Statistics OFPROFIT & LOSS – GROUP (2H FY2022) IT & LOSS – GROUP (2H FY2022) PROFIT & LOSS – GROUP (2H FY2022) FY2021 FY2022 FY2023 1H FY2024 LICENSED BEDS(1) Singapore 187 187 187 187 Malaysia 205 308 350 350 Vietnam4 N.A. N.A. N.A. 230 Total 392 495 537 767 OPERATIONAL BEDS(2) Singap
Slide 19: Key Operating Statistics
Key Operating Statistics FY2021 FY2022 FY2023 1H FY2024 NUMBER OF INPATIENT Singapore 20,402 20,972 20,315 9,221 Malaysia 18,806 23,107 29,390 16,246 Vietnam(2) N.A. N.A. N.A. 4,023 Total 39,208 44,079 49,705 29,490 NUMBER OF OUTPATIENT Singapore 277,398 308,308 288,638 129,783 Malaysia 166,254 183,
Slide 20: Future Growth Plans
4 Future Growth Plans Confidential I 19
Slide 21: TMG Going Forward: Firing on all Cylinders
TMG Going Forward: Firing on all Cylinders • Strategic high-value healthcare markets • Markets offering high growth potential, especially leveraging the Group’s Regional stronghold in Singapore, Malaysia and Vietnam Expansion • A localised approach to each market to maximise each geography’s unique
Slide 22: Thank You!
Thomson Medical Group Limited THANK YOU! 101 Thomson Road #20-04/05 United Square Singapore 307591 Confidential I 21
Thomson Medical Group — H1 2024 Earnings Presentation on 6ix